68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy.

Andrea FarolfiFrancesco CeciPaolo CastellucciTiziano GrazianiGiambattista SiepeAlessandro LambertiniRiccardo SchiavinaFilippo LodiAlessio G MorgantiStefano Fanti

Published in: European journal of nuclear medicine and molecular imaging (2018)

In our patient series with PSA levels <0.5 ng/ml, 68Ga-PSMA-11 PET/CT had a detection rate of 34.4%. In the ITT analysis, 30.2% of patients had a change in the intended treatment. These data support the hypothesis that 68Ga-PSMA-11 PET/CT is a useful procedure in the management of PCa patients showing early recurrence after RP, and should be implemented in routine clinical practice.

Keyphrases

pet ct
prostate cancer
radical prostatectomy
clinical practice
positron emission tomography
ejection fraction
end stage renal disease
newly diagnosed
computed tomography
case report
electronic health record
minimally invasive
combination therapy
data analysis